These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 420954)

  • 1. Clinical pharmacological studies on 5-FU treatment for advanced gastro-intestinal carcinomas.
    Carcassonne Y; Seitz JF; Cano JP
    Bull Cancer; 1979; 66(1):97-100. PubMed ID: 420954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
    Tsuji Y; Yoshihito H; Nakamura T; Watanabe Y; Nakayama N; Ohi M; Kawanishi J; Handa H; Honjo K; Uehara S
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():439-46. PubMed ID: 8849290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer].
    Tsuji Y; Nakamura T; Katagiri E; Kawanishi J; Handa H; Honjo K; Uehara S; Izumiyama S; Hirayama A; Sagawa T
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():419-25. PubMed ID: 7802444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protracted ambulatory venous infusion of 5-fluorouracil.
    Lokich J; Fine N; Perri J; Bothe A
    Am J Clin Oncol; 1983 Feb; 6(1):103-7. PubMed ID: 6837501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outpatient chemotherapy with weekly high-dose infusional 5-fluorouracil (weekly HD-FU) in advanced gastrointestinal cancer].
    Tsuji Y; Kuroiwa G; Kato M; Ohi M; Handa H; Honjo K; Uehara S; Hirayama A
    Gan To Kagaku Ryoho; 1998 Dec; 25 Suppl 4():619-24. PubMed ID: 9884653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.
    Sugarbaker PH; Gianola FJ; Speyer JC; Wesley R; Barofsky I; Meyers CE
    Surgery; 1985 Sep; 98(3):414-22. PubMed ID: 3898450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].
    Shirasaka T; Aiba K; Araki H; Suzuki M; Terashima M; Mikami Y
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):456-66. PubMed ID: 10097742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas.
    Caballero GA; Ausman RK; Quebbeman EJ
    Cancer Treat Rep; 1985 Jan; 69(1):13-5. PubMed ID: 3155649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer.
    Seymour MT; Trigonis I; Finan PJ; Halstead F; Dunham R; Wilson G; Farrugia D; Chester JD; King J; Brown CB; Slevin ML; Joel SP
    Eur J Surg Oncol; 2008 Apr; 34(4):403-9. PubMed ID: 17604939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I evaluation and pharmacokinetic study of weekly iv thymidine and 5-FU in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Chun H; Martin D; Young C
    Cancer Treat Rep; 1985 Feb; 69(2):179-84. PubMed ID: 3971391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological study on levofolinate in intraperitoneal leucovorin-5-FU chemotherapy].
    Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K; Ochiai T; Natsui S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2199-201. PubMed ID: 12484036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outpatient chemotherapy with infusional 5-fluorouracil in advanced gastrointestinal cancer].
    Tsuji Y; Miyajima N; Kuroiwa G; Kato M; Nobuoka A; Ohi M; Honjo K
    Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():346-50. PubMed ID: 10630245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer.
    Martoni A; Cricca A; Guaraldi M; Covizzi M; Farris A; Pannuti F
    Anticancer Res; 1992; 12(3):607-12. PubMed ID: 1622115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS; Mangalik A; Ferguson J; Elias L
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
    Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.